3 completed, 2 terminated. 4 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Not applicable | 1 | Terminated 1 |
Follow apricoxib: new trials by email Literature Review of apricoxib trials Research Report on apricoxib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer Apricoxib - Non Small Cell Lung Cancer | Not applicable | Terminated | Jonsson Comprehensive Cancer Center | 1 | 2011-11-01 | 2020-09-22 |
| 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer apricoxib, Placebo, Docetaxel or Pemetrexed - Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | Completed | University of Maryland, Baltimore | 109 | 2008-11-01 | 2019-10-30 |
| APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer gemcitabine, placebo, Erlotinib - Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Completed | Tragara Pharmaceuticals, Inc. | 109 | 2008-08-01 | 2012-11-07 |
| APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) apricoxib + lapatinib + capecitabine, placebo + lapatinib + capecitabine - Breast Cancer | Phase 2 | Terminated | Tragara Pharmaceuticals, Inc. | 12 | 2008-04-01 | 2012-03-15 |
| APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer apricoxib/erlotinib, erlotinib/placebo - Recurrent Non Small Cell Lung Cancer | Phase 2 | Completed | Tragara Pharmaceuticals, Inc. | 120 | 2008-04-01 | 2012-04-09 |
Carcinoma, Non-Small-Cell Lung (3) · Breast Neoplasms (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1)
Tragara Pharmaceuticals, Inc. (3) · Jonsson Comprehensive Cancer Center (1) · University of Maryland, Baltimore (1)
United States (5)
Tracy Parrott (2) · Jay M Lee, M.D. (1) · Martin J Edelman (1) · Sara Zaknoen, M.D. (1)